Kyowa Hakko Kirin signs AI drug R&D deal with InveniAI

Kyowa Hakko Kirin signs AI drug R&D deal with InveniAI

Source: 
Pharmaforum
snippet: 

Artificial intelligence and machine learning company InveniAI has joined with Kyowa Hakko Kirin to harness the power of technology for drug discovery.